BackAgeX Therapeutics Overview

AgeX Therapeutics Total Liabilities

Track AgeX Therapeutics's total liabilities ($9.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.67M
↑ 86.99% YoYΔ $4.50M vs prior year quarter

Peer average

Loading

AgeX Therapeutics Total Liabilities History

Loading

AgeX Therapeutics vs. peers: Total Liabilities Comparison

Loading

AgeX Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AgeX Therapeutics (AGE) FAQ

AgeX Therapeutics (AGE) currently reports a total liabilities of $9.7M as of March 2026. That compares with $5.2M in the prior-year period — up 87.0% year over year. Use the charts on this page to explore AgeX Therapeutics's total liabilities history and peer comparisons.

AgeX Therapeutics's total liabilities increased from $5.2M to $9.7M — a 87.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AgeX Therapeutics reported $9.7M in total liabilities as of March 2026. That compares with $5.2M in the prior-year period — up 87.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $9.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AgeX Therapeutics, and consider following AGE for alerts when major investors trade the stock.

AgeX Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $9.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGE with unrelated industries.